ArticleFrontiers in neurology2022

Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study.

Yangfan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.